Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs GPC✓SelectedUSD · GPCGSK vs GPC performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs GPC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
GPC return
+3.1%
Excess return
+43.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGPCExcessAlpha
1D-0.1%-0.9%+0.9%+0.1%
7D-1.3%-2.8%+1.5%-0.8%
30D+2.7%-8.8%+11.5%+4.5%
3M+2.7%-8.8%+11.5%+4.5%
6M+3.3%+34.0%-30.7%-2.2%
YTD+6.5%+2.2%+4.3%+4.7%
1Y+10.7%-0.5%+11.2%+9.3%
3Y+64.4%-2.2%+66.6%+60.1%
5Y+46.7%+3.2%+43.5%+37.2%
All+46.7%+3.1%+43.6%+37.2%

Cumulative growth

Daily Returns

Daily percentage return beside GPC.

Daily Out/Under-Performance

Portfolio return minus GPC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GPC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GPC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling